
Ylorab IV 20mg Injection
Marketer
Barlis Lifesciences Pvt Ltd
Salt Composition
Rabeprazole (20mg)
Overview Ylorab IV 20mg Injection
Intravenous Ylorab (20mg) is a rapid-acting medication that suppresses gastric acid production. It's indicated for various gastrointestinal disorders characterized by excessive acidity, including acid reflux, indigestion, peptic ulcers, and other related conditions. Ylorab provides swift relief from acidity symptoms and is also prophylactically used to prevent stress ulcers in critically ill patients and pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), this injection is administered intravenously by a healthcare professional only when deemed more appropriate than oral administration. Dosage and treatment duration are determined by your physician based on individual needs and response. Optimal treatment involves adhering to the prescribed regimen, even with symptom resolution, and adopting lifestyle modifications like smaller, more frequent meals, while avoiding caffeine, spicy foods, and fatty meals. Common side effects, typically mild, include nausea, vomiting, headache, dizziness, flatulence, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects warrant medical attention. Prolonged use, particularly exceeding one year, may increase the risk of fractures, especially at higher doses. Discuss bone health strategies with your doctor, such as calcium and vitamin D supplementation. Hypomagnesemia (low magnesium) has been reported in patients using this medication for three months or longer, potentially causing fatigue, confusion, dizziness, muscle spasms, and arrhythmias. Magnesium levels may be monitored by your physician. Ylorab is contraindicated in certain individuals. Inform your physician of any severe liver impairment, HIV medication use, prior allergic reactions to similar medications, existing osteoporosis, or pregnancy/breastfeeding. Alcohol should be avoided due to its acid-stimulating properties. Refrain from operating machinery or driving if experiencing dizziness or drowsiness.
Primary Ingredients of Ylorab IV 20mg Injection
There is no text provided to rephrase.
Uses of Ylorab IV 20mg Injection
Management of acid indigestion and peptic ulcers
Major Benefits of Ylorab IV 20mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ylorab IV 20mg Injection:
- Nausea
- Vomiting
- Headache
- Dizziness
- Flatulence
- Diarrhea
- Stomach pain
- Thrombophlebitis
How to use Ylorab IV 20mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ylorab IV 20mg Injection works:
Gastric acid secretion is inhibited by the intravenous administration of Ylorab 20mg, a proton pump inhibitor (PPI), thereby alleviating heartburn and acid indigestion symptoms.
SAFETY ADVICE
AlcoholCAUTION
Patients using Ylorab IV 20mg Injection should exercise caution when drinking alcohol. Medical advice is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Ylorab IV 20mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Administration of Ylorab IV 20mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Ylorab IV 20mg Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Administration of Ylorab IV 20mg Injection is considered safe for individuals with impaired renal function. No modification of the Ylorab IV 20mg Injection dosage is necessary.
LiverCAUTION
Administering Ylorab IV 20mg Injection requires careful consideration in individuals with advanced hepatic impairment. Dosage modification of Ylorab IV 20mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Ylorab IV 20mg Injection :
Omit a dose of Ylorab IV 20mg Injection? Seek your physician's advice.
Facts to Know About Ylorab IV 20mg Injection
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Category | Gastric acid suppressants |
